These changes suggested reduced capacity of CP to maintain CSF T4 homeostasis, and could also reduce chelation of beta-amyloid, which may result in an added risk for Alzheimer's disease in patients experiencing similar changes in TTR synthesis. This evidence concerns the gene CP and early-onset autosomal dominant Alzheimer disease.